Chief Executive Officer
Innova Vascular, Inc.
Irvine, California, United States
Bio-sketch of Dr. Sanjay Shrivastava
Dr. Sanjay Shrivastava is the founder and CEO of Innova Vascular, Inc., a company engaged in developing innovative cardiovascular medical devices. Prior to founding Innova, Sanjay cofounded BlackSwan Vascular, which is a medical device startup company that developed the first liquid embolic agent approved for a peripheral vascular use in the USA and has been acquired by Sirtex Medical Limited, a subsdiary of Grand China Pharmaceuticals. Sanjay also serves as a member of the board of directors at enVVeno Medical Corporation, which is a Nasdaq traded (ticker: NVNO) medical device company headquartered in Irvine, CA.
Sanjay has been involved in developing, commercializing, evaluating, and acquiring medical devices for over 25 years. During his career, Sanjay has held positions at leading medical device companies including senior director, business development at Johnson & Johnson, vice president, upstream marketing and strategy at BTG, plc. (a publicly traded company that was acquired by Boston Scientific Corporation), director global marketing at Medtronic and director, research & development at Covidien/ev3 (merged with Medtronic).
Sanjay holds 31 issued US patents and numerous international patents in medical devices and has edited two books including one titled “Medical Device Materials” published by ASM International. He was named among 100 Notable People in Medical Device Industry by the prestigious MD&DI (Medical Devices and Diagnostics Industry) magazine. He has been an invited speaker at clinical, business, and engineering conferences to speak about medical device innovation and commercialization. Sanjay holds a doctorate in materials science and engineering from the University of Florida and a bachelor’s from the Indian Institute of Technology.
Friday, May 9, 2025
1:56 PM - 2:20 PM East Coast USA Time